Survival outcomes
The 2-year overall survival (OS) of the whole cohort was 33%, (Figure 2A). When assessing the impact of clinical factors on survival, it was found that an elevated IPI score ranging from 3 to 5 was indicative of a poorer outcome (p= 0.017, Figure 2B). Despite the limited number of events (n=7), there appears to be no significant association between the occurrence of TLS and altered survival outcomes (p= 0.64, Figure 2C).